SunLink Health Systems, Inc. Announces Fiscal 2024 Fourth Quarter and Annual Results
ATLANTA–(BUSINESS WIRE)–SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $652,000 (or a loss of... Read more.
EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit on Behalf of Paragon 28, Inc. Investors – FNA
NEW YORK–(BUSINESS WIRE)–Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of... Read more.
Elevance Health Responds to Communities Affected by Hurricane Helene
Grant to support communities in recovery and rebuilding INDIANAPOLIS–(BUSINESS WIRE)–Elevance Health and its philanthropic arm, Elevance Health Foundation,... Read more.
X-energy Appoints Joel Duling as President of its TRISO-X Advanced Nuclear Fuel Unit
OAK RIDGE, Tenn.–(BUSINESS WIRE)–X-energy Reactor Company, LLC (“X-energy” or the “Company”), a leading developer of advanced small modular nuclear... Read more.
Barclays appoints Bradley Rogoff as Global Head of Research
Mr. Rogoff joined the firm in 2002 and currently serves as the Head of FICC Research LONDON & NEW YORK–(BUSINESS WIRE)–Barclays today announces the... Read more.
Vanto Group Recognized by Forbes as one of the World’s Best Management Consulting Firms for 2024
FT. LAUDERDALE, Fla.–(BUSINESS WIRE)–Vanto Group, a global leader in organizational transformation and team performance, has been named one of the World’s... Read more.
CRWD Deadline: Rosen Law Firm Urges CrowdStrike Holdings, Inc. (NASDAQ: CRWD) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
NEW YORK–(BUSINESS WIRE)–Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of all... Read more.
FIVE Deadline: Rosen Law Firm Urges Five Below, Inc. (NASDAQ: FIVE) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
NEW YORK–(BUSINESS WIRE)–Rosen Law Firm, a global investor rights law firm, reminds investors a shareholder filed a class action on behalf of all purchasers... Read more.
Alnylam Highlights New Data From HELIOS-B Study of Vutrisiran for the Treatment of Transthyretin Amyloidosis With Cardiomyopathy at Heart Failure Society of America Annual Scientific Meeting 2024
− Echocardiographic and Cardiac Biomarker Data From the HELIOS-B Study Presented Today Support the Potential of Vutrisiran in ATTR-CM – − Vutrisiran Significantly... Read more.
Emulate, Inc. Unveils the Chip-R1™ Rigid Chip with a Minimally Drug-Absorbing Profile to Improve Biological Modeling for ADME and Toxicology Applications
BOSTON–(BUSINESS WIRE)–Emulate, Inc., the leading provider of next-generation in vitro Organ-Chip models, today announced the release of its new Chip-R1™... Read more.